Araştırma Makalesi

Interleukin-1 gene variants and the risk of non-syndromic microtia

Cilt: 11 Sayı: 2 14 Mayıs 2018
  • Ayşe Feyda Nursal *
PDF İndir
EN TR

Interleukin-1 gene variants and the risk of non-syndromic microtia

Abstract

INTRODUCTION: Microtia is a congenital anomaly, manifested by a small and disfigured auricle. Interleukin (IL) 1 is an important mediator of inflammation and cartilage destruction, This study is aimed at investigating association of IL-1A (-889) and IL-1B (-511) variants in a Turkish patient population with microtia.
METHODS: Nineteen patients diagnosed with microtia and 40 healthy controls were enrolled to the study. The IL-1A (-889) and IL-1B (-511) variants were evaluated using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. For statistical analysis, SPSS version 22.0 was used.
RESULTS: The genotype distribution of the IL-1A (-889) variant was statistically different between the cases and the control group. IL-1A -889 CC genotype was lower in microtia cases while TT genotype was more prevalent in microtia cases, respectively (p=0.008, p=0.008). High difference was also observed when the patient group and the control group were compared according to IL-1 (-889) CT+TT (p=0.003). IL-1A (-889) C allele was lower in microtia patients and T allele was higher in patients (p=0.005). The allele frequency and genotype distribution of IL-1B (-511) CT variant did not show any statistically difference between patients and controls (p>0.05).
DISCUSSION AND CONCLUSION: To our knowledge, for the first time in the literature we have demonstrated a significant association of the IL-1A (-889) functional variant with microtia in a Turkish cohort.

İngilizce Kısa Başlık: IL-1 gene variants in microtia

Keywords

Kaynakça

  1. 1. Luquetti DV, Heike CL, Hing AV, Cunningham ML, Cox TC. Microtia: Epidemiology and genetics. Am J Med Genet A 2012;158A:124-39.
  2. 2. Cremers CW. Meatal atresia and hearing loss. Autosomal dominant and autosomal recessive inheritance. Int J Pediatr Otorhinolaryngol 1985;8:211-213.
  3. 3. Vishnoi M, Pandey SN, Choudhuri G, Mittal B. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population. Cancer Genet Cytogenet 2008;186:63-68.
  4. 4. Kruessel JS, Huang HY, Wen Y, Kloodt AR, Bielfeld P, Polan ML. Different pattern of interleukin-1 beta-(IL-1 beta), interleukin-1 receptor antagonist- (IL-1ra) and interleukin-1 receptor type I- (IL-1R tI) mRNA-expression in single preimplantation mouse embryos at various developmental stages. J Reprod Immunol 1997;34(2):103-120.
  5. 5. Cortial D, Gouttenoire J, Rousseau CF, et al. Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds with therapeutic potential in osteoarthritis. Osteoarthritis Cartilage 2006;14:631-640.
  6. 6. Haroon J, Hussain S, Javed Q. Heritability of IL-1A Gene Promoter Polymorphism in Patients With Coronary Artery Disease: A Trio-Family Study. Lab Med 2015;46:20-25.
  7. 7. di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992;1:450.
  8. 8. Achyut BR, Srivastava A, Bhattacharya S, Mittal B. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta 2007;377:163-169.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yazarlar

Ayşe Feyda Nursal * Bu kişi benim
Hitit Üniversitesi Tıp Fakültesi Tıbbi Genetik Ad. Çorum
Türkiye

Yayımlanma Tarihi

14 Mayıs 2018

Gönderilme Tarihi

27 Temmuz 2017

Kabul Tarihi

19 Eylül 2017

Yayımlandığı Sayı

Yıl 2018 Cilt: 11 Sayı: 2

Kaynak Göster

AMA
1.Nursal AF. Interleukin-1 gene variants and the risk of non-syndromic microtia. Pam Tıp Derg. 2018;11(2):89-94. doi:10.5505/ptd.2017.94557
Creative Commons Lisansı
Pamukkale Tıp Dergisi, Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır